Research programme: peptide therapeutics - Psylin Neurosciences
Alternative Names: PSN 0041; PSN0240 (Peptide 2); PSN0459 (Peptide 3); PSN0484 (Peptide 1); PSN0484 analogues - Amylin/Psychogenics; PSN0485; PSN0486; PSN0487Latest Information Update: 16 Jul 2016
At a glance
- Originator Psylin Neurosciences
- Class Peptide hormones; Peptides
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder; Psychiatric disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Major depressive disorder in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Psychiatric-disorders in USA (Parenteral)
- 21 Oct 2009 Preclinical trials in Psychiatric disorders in USA (Parenteral)